INDIANAPOLIS , Feb. 24, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 41 st Annual Health Care Conference on Thursday, March 4, 2021 . Daniel Skovronsky , M.D., Ph.D., Lilly 's Chief Scientific Officer and President of Lilly Research Laboratories

INDIANAPOLIS , Feb. 11, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 . Ilya Yuffa , Lilly senior vice president and president of Lilly Bio-Medicines, will participate in a fireside

INDIANAPOLIS , Feb. 4, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, March 15, 2021 to provide an update on its Alzheimer's disease program and discuss results from the Phase 2 TRAILBLAZER-ALZ study for donanemab being presented at the 15th International

INDIANAPOLIS , Feb. 3, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, February 12, 2021 . Anne White , senior vice president and president, Lilly Oncology, and Jacob Van Naarden , chief executive officer of

- Revenue in the fourth quarter of 2020 increased 22 percent, driven by volume growth of 24 percent. Excluding bamlanivimab revenue of $871 million, fourth-quarter 2020 revenue grew 7 percent. - Full-year 2020 revenue increased 10 percent, driven by volume growth of 15 percent.

INDIANAPOLIS , Jan. 15, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the

INDIANAPOLIS , Jan. 4, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the 39 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 . David A. Ricks , Lilly 's chairman and chief executive officer, will participate in a virtual fireside chat at 8:20 a.m.

- Lilly expects to deliver strong financial and operational performance in 2021, highlighted by volume-based revenue growth, operating margin expansion, pipeline advancements and solid cash flow. - 2021 revenue is expected to be between $26.5 billion and $28.0 billion, driven by volume growth from

INDIANAPOLIS , Dec. 14, 2020 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 15 percent increase in its quarterly dividend. The dividend for the first quarter of 2021 will be $0.85 per share on outstanding common stock.

INDIANAPOLIS , Dec. 8, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2021 on Tuesday, December 15, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial